Status:
RECRUITING
Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colorectal Lesions
Lead Sponsor:
The First Hospital of Jilin University
Conditions:
Endocytoscopy
Eligibility:
All Genders
Brief Summary
Colorectal cancer (colorectal cancer, CRC) is the third most common malignant tumor globally and the second leading cause of cancer-related deaths. Colonoscopy is considered the preferred method for s...
Eligibility Criteria
Inclusion
- colorectal lesions
Exclusion
- lesions lacking high-quality images;
- Inflammatory bowel disease, familial adenomatous polyposis and other special diseases;
- submucosal tumors;
- Pathological diagnosis of Peutz-Jeghers polyps, juvenile polyps, lymphoma and other pathological types.
Key Trial Info
Start Date :
May 21 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06982872
Start Date
May 21 2025
End Date
December 31 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Hospital of Jilin University
Changchun, Jilin, China, 130021